Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potential HLA-matched platelet donor availability for alloimmunized patients.

C A Schiffer, C Keller, J P Dutcher

    Transfusion
    |July 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Commentary on: 'Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia'.

    Leukemia·2016
    Same author

    Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia.

    Leukemia·2012
    Same author

    Investigations of peptide hydration using NMR and molecular dynamics simulations: A study of effects of water on the conformation and dynamics of antamanide.

    Journal of biomolecular NMR·2010
    Same author

    Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002.

    Leukemia·2003
    Same author

    Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL(1).

    Leukemia·2003
    Same author

    Postremission therapy in older adults with acute myeloid leukemia: an opportunity for new drug development.

    Leukemia·2002

    Finding HLA-matched donors for alloimmunized patients is challenging. Current HLA typing technology limits donor availability, potentially hindering long-term platelet transfusion support for those with rare HLA types.

    Area of Science:

    • Immunology
    • Transfusion Medicine
    • Genetics

    Background:

    • Alloimmunized patients require HLA-matched platelet transfusions for effective support.
    • Identifying suitable donors is crucial for managing these patients, especially those with leukemia.

    Purpose of the Study:

    • To analyze the availability of Human Leukocyte Antigen (HLA)-matched donors for alloimmunized patients.
    • To assess the impact of HLA matching limitations on long-term platelet transfusion support.

    Main Methods:

    • Computer searches were conducted for HLA-matched donors for 100 alloimmunized patients.
    • Donor availability was assessed considering perfect matches, no mismatches, and single antigen/cross-reactive mismatches.

    Main Results:

    Related Experiment Videos

    • An average of only 1.3 perfectly matched donors were available per patient from a pool of 2470 donors.
    • Donor availability increased with consideration of mismatches, but estimates were lower than previously reported.
    • Patients with uncommon HLA types had fewer available donors, often relying on family members.

    Conclusions:

    • Current HLA typing technology presents limitations in identifying sufficient donors for alloimmunized patients.
    • Long-term platelet transfusion support may be difficult for patients with unusual HLA types.
    • Consideration of donor availability is essential when planning treatment for alloimmunized leukemia patients.